Vishnu K: The Growing Role of RET-He in Modern Hematology
Vishnu K, Hematopathology Postgraduate at Nitte University, shared a post on LinkedIn:
“RET-He: Precision Anemia Management.
Early detection is the key to effective anemia management. Reticulocyte Hemoglobin Equivalent (RET-He) is emerging as a powerful biomarker that assesses the real-time availability of iron for red blood cell production—often identifying iron deficiency before changes in hemoglobin become apparent.
By enabling earlier diagnosis, monitoring response to iron therapy within days, and supporting anemia management in conditions such as chronic kidney disease, inflammation, pregnancy, and pediatric populations, RET-He is advancing a more precise and personalized approach to patient care.
As laboratory medicine continues to evolve, innovative biomarkers like RET-He are helping clinicians make faster, evidence-based decisions that improve patient outcomes.
Precision diagnostics. Timely intervention. Better patient care.”
Stay updated with Hemostasis Today.
-
Jun 27, 2026, 12:33María Gabriela Muñoz: TOAST Criteria and Outcomes in Ischemic Stroke
-
Jun 27, 2026, 12:17Navid Radfar: Moving Beyond CHA₂DS₂-VASc and De-Risking Atrial Fibrillation
-
Jun 27, 2026, 12:11Gianluca De Rubeis: A Safer Approach to Antiplatelet Timing in Endovascular Aneurysm Treatment
-
Jun 27, 2026, 12:09Mapillar Dahn: Empowering Sickle Cell Warriors Through Awareness and Support
-
Jun 27, 2026, 12:00Ney Carter Borges: FAVOR III China Demonstrates a 37% Reduction in Myocardial Infarction with QFR Guidance
-
Jun 27, 2026, 11:52Abuzar Ghaffari: A Proud Milestone in My Professional Journey at ISBT 2026
-
Jun 27, 2026, 05:53Manuel Gutiérrez de Ravé: My Personal Takeaways from 39th International ISBT Annual Congress
-
Jun 27, 2026, 05:4710-Minute Paper-Strip Test Detects Factor VIII Inhibitors in Resource-Limited Settings – JTH
-
Jun 27, 2026, 05:23New episode – From Groundbreaking Therapies to the Ongoing Fight for Diagnosis – Global Hemophilia Report